- Unit – II (Gandhinagar):
Finished dosage manufacturing facility. - Unit – IIIA (Jeedimetla):
Finished dosage manufacturing facility for semi-regulatory markets – WHO Approved - Unit – IIIB (Jeedimetla):
Finished dosage manufacturing facility for regulatory markets – USFDA Approved - Unit – V (Baddi):
Finished dosage manufacturing facility for Indian market - Unit – II (Baddi):
Finished dosage manufacturing facility for semi-regulatory & Indian markets - Unit – V (Jedcherla):
Solid & Liquid finished dosage manufacturing facility for semi-regulatory & regulatory markets - Unit – VI (Jedcherla):
Dedicated Oncology finished dosage manufacturing facility for semi- regulatory & regulatory markets - Manufacturing facility for generic finished dosages
2. HETERO LABS LTD.
3. INVAGEN PHARMACEUTICALS INC., USA



